{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:42:22Z","timestamp":1783734142230,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.autrev.2024.103713","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T17:11:34Z","timestamp":1732900294000},"page":"103713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Wenxuan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanmei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anji","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103713_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2013","key":"10.1016\/j.autrev.2024.103713_bb0010","first-page":"1","article-title":"Revised international Chapel Hill consensus conference nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103713_bb0015","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","volume":"59","author":"Wallace","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103713_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa035","article-title":"Immunosuppressive and glucocorticoid therapy for the treatment of ANCA-asssociated vasculitis","volume":"59","author":"Neumann","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103713_bb0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0035","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","article-title":"Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study","volume":"60","author":"Rathmann","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103713_bb0040","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"Jama"},{"key":"10.1016\/j.autrev.2024.103713_bb0045","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2024.103713_bb0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.autrev.2024.103713_bb0055","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.autrev.2024.103713_bb0060","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1177\/09622802211047348","article-title":"Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis","volume":"30","author":"Cai","year":"2021","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.autrev.2024.103713_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110342","article-title":"Infectious risk when prescribing rituximab in patients with hypogachanlmmaglobulinemia acquired in the setting of autoimmune diseases","volume":"120","author":"Boumaza","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2024.103713_bb0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard-2022-223401","article-title":"Risk factors for serious infections in ANCA-associated vasculitis","volume":"82","author":"Odler","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0075","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1007\/s10067-022-06314-9","article-title":"Predicting bacterial infection risk in patients with ANCA-associated vasculitis in Southwest China: development of a new nomogram","volume":"41","author":"Zhang","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/rheumatology\/keab293","article-title":"Severe infections in patients with ANCA-associated vasculitis treated with rituximab","volume":"61","author":"Segelmark","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103713_bb0085","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/rheumatology\/keaa541","article-title":"Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models","volume":"60","author":"McClure","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103713_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nefroe.2021.07.005","article-title":"The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: a retrospective study","volume":"41","author":"Fonseca","year":"2021","journal-title":"Nefrologia (Engl Ed)"},{"key":"10.1016\/j.autrev.2024.103713_bb0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12941-021-00483-2","article-title":"Epidemiology, mortality and effectiveness of prophylaxis for pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study","volume":"20","author":"Chan","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.autrev.2024.103713_bb0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/0886022X.2020.1763400","article-title":"Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients","volume":"42","author":"Yin","year":"2020","journal-title":"Ren Fail"},{"key":"10.1016\/j.autrev.2024.103713_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019173","article-title":"Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective observational study","volume":"99","author":"Waki","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2024.103713_bb0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00296-020-04752-9","article-title":"Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis","volume":"41","author":"Speer","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2024.103713_bb0115","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/rheumatology\/keaa070","article-title":"Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis: results from a longitudinal, matched-cohort data linkage study","volume":"59","author":"Sarica","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103713_bb0120","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s10067-020-05068-6","article-title":"Infective patterns of cryptococcosis in patients with connective tissue disease: a retrospective study","volume":"39","author":"Lao","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3899\/jrheum.190065","article-title":"Prevalence and risk factors for major infections in patients with Antineutrophil cytoplasmic antibody\u2013associated Vasculitis: influence on the disease outcome","volume":"47","author":"Garcia-Vives","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0130","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00296-020-04661-x","article-title":"Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study with a clinical phenotype approach","volume":"40","author":"Caballero-Islas","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2024.103713_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4300-0","article-title":"Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"19","author":"Yamaguchi","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0140","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/1756-185X.13662","article-title":"Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis, using a Japanese health insurance database","volume":"22","author":"Sakai","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218705","article-title":"Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"Morishita","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2024.103713_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10067-019-04779-9","article-title":"Infectious profile in inpatients with ANCA-associated vasculitis: a single-center retrospective study from southern China","volume":"39","author":"Lao","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0155","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s10067-018-4067-5","article-title":"Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis","volume":"37","author":"Yoo","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12882-018-0933-2","article-title":"Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study","volume":"19","author":"Yang","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.autrev.2024.103713_bb0165","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s10067-018-4155-6","article-title":"Late-onset pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis","volume":"37","author":"Matraiah","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0170","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3899\/jrheum.180310","article-title":"Zoster after cyclophosphamide for systemic lupus erythematosus or Vasculitis: incidence, risk factors, and effect of antiviral prophylaxis","volume":"45","author":"Garnier","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/03009742.2018.1461924","article-title":"Long-term risk and outcome of infection-related hospitalization in granulomatosis with polyangiitis: a nationwide population-based cohort study","volume":"47","author":"Faurschou","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0180","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/14397595.2016.1226468","volume":"27","author":"Watanabe-Imai","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/ckj\/sfx014","article-title":"Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"10","author":"Shah","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2024.103713_bb0190","doi-asserted-by":"crossref","first-page":"723","DOI":"10.6061\/clinics\/2017(12)02","article-title":"Serum 25-hydroxyvitamin D levels in patients with granulomatosis with Polyangiitis: association with respiratory infection","volume":"72","author":"Perez","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.autrev.2024.103713_bb0195","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3899\/jrheum.160909","article-title":"Severe infection in Antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"44","author":"Mohammad","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10157-015-1199-7","article-title":"Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis","volume":"20","author":"Kitagawa","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2024.103713_bb0205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000843","article-title":"The CD4 lymphocyte count is a better predictor of overall infection than the Total lymphocyte count in ANCA-associated Vasculitis under a corticosteroid and cyclophosphamide regimen: a retrospective cohort","volume":"94","author":"Shi","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2024.103713_bb0210","doi-asserted-by":"crossref","first-page":"i171","DOI":"10.1093\/ndt\/gfv045","article-title":"Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function","volume":"30","author":"McGregor","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2024.103713_bb0215","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3899\/jrheum.131426","article-title":"Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients","volume":"41","author":"Lai","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0220","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2215\/CJN.07300712","article-title":"Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis","volume":"8","author":"Goupil","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2024.103713_bb0225","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s00296-011-2151-0","article-title":"Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement","volume":"32","author":"Morton","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2024.103713_bb0230","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/RHU.0b013e31819e67b1","article-title":"Invasive pulmonary aspergillosis in patients with antineutrophil cytoplasmic antibody associated vasculitis","volume":"15","author":"Su","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0235","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.2008.088302","article-title":"Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients","volume":"68","author":"Charlier","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0240","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.06.012","article-title":"Herpes zoster in immunocompromised patients: incidence, timing, and risk factors","volume":"118","author":"Wung","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2024.103713_bb0245","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/rheumatology\/keh522","article-title":"ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients","volume":"44","author":"Harper","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103713_bb0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20082","article-title":"Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients","volume":"51","author":"Bligny","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103713_bb0255","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/S0041-1345(02)03514-5","article-title":"Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis","volume":"34","author":"Koselj-Kajtna","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.autrev.2024.103713_bb0260","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener\u2019s granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2024.103713_bb0265","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review","volume":"26","author":"Falagas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0270","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/acr.25222","article-title":"Incidence of pneumocystis Jiroveci pneumonia in patients with ANCA-associated Vasculitis initiating therapy with rituximab or cyclophosphamide","volume":"76","author":"Nettleton","year":"2024","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2024.103713_bb0275","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.39614","article-title":"Trends in long-term outcomes among patients with Antineutrophil cytoplasmic antibody-associated Vasculitis with renal disease","volume":"68","author":"Rhee","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10157-018-1641-8","article-title":"Clinical epidemiology of infectious disease among patients with chronic kidney disease","volume":"23","author":"Ishigami","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2024.103713_bb0285","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2016.09.018","article-title":"CKD and risk for hospitalization with infection: the atherosclerosis risk in communities (ARIC) study","volume":"69","author":"Ishigami","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0290","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.ajkd.2011.07.012","article-title":"The risk of infection-related hospitalization with decreased kidney function","volume":"59","author":"Dalrymple","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0295","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1046\/j.1523-1755.2002.00279.x","article-title":"Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency","volume":"61","author":"Haubitz","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2024.103713_bb0300","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2215\/CJN.03190321","article-title":"Disease activity and adverse events in patients with ANCA-associated Vasculitides undergoing long-term Dialysis","volume":"16","author":"Kauffmann","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2024.103713_bb0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2024.103713_bb0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12890-022-01829-y","article-title":"Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients","volume":"22","author":"Zhou","year":"2022","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2024.103713_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102397","article-title":"Alveolar haemorrhage in ANCA-associated vasculitis: long-term outcome and mortality predictors","volume":"108","author":"Quartuccio","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103713_bb0320","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/thoraxjnl-2011-200206","article-title":"Immunity and bacterial colonisation in bronchiectasis","volume":"67","author":"Whitters","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2024.103713_bb0325","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/cid\/ciy723","article-title":"Prevalence and etiology of community-acquired pneumonia in immunocompromised patients","volume":"68","author":"Di Pasquale","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2024.103713_bb0330","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/art.40937","article-title":"Predicting severe infection and effects of Hypogammaglobulinemia during therapy with rituximab in rheumatic and musculoskeletal diseases","volume":"71","author":"Md Yusof","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0335","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1093\/rheumatology\/kead138","article-title":"Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study","volume":"62","author":"Omura","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103713_bb0340","first-page":"603","article-title":"Hypoalbuminaemia in antineutrophil cytoplasmic antibody-associated vasculitis: incidence and significance","volume":"36","author":"Xu","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103713_bb0345","first-page":"1","volume":"51","author":"Boyce","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.autrev.2024.103713_bb0350","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with Cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.autrev.2024.103713_bb0355","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Diagnosis of severe respiratory infections in immunocompromised patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.autrev.2024.103713_bb0360","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2024.103713_bb0365","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","article-title":"Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals","volume":"47","author":"Li","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.autrev.2024.103713_bb0370","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2024.103713_bb0375","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/annonc\/mdu192","article-title":"Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"26","author":"Maschmeyer","year":"2015","journal-title":"Ann Oncol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224002040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224002040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T02:22:27Z","timestamp":1738462947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224002040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1568997224002040"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103713","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103713"}}